Zoetis (ZTS) Operating Income (2012 - 2026)
Zoetis' (ZTS) quarterly Operating Income came in at $837.0 million in Q2 2026, down 10.0% year-over-year from $930.0 million in Q2 2025, and up 20.09% quarter-over-quarter from $697.0 million in Q1 2026.
Analysis
Zoetis (ZTS) Operating Income (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Operating Income for 15 consecutive years, with $837.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Operating Income fell 10.0% year-over-year to $837.0 million in Q2 2026; TTM through Jun 2026 was $2.2 billion, a 6.12% decrease from a year earlier, with the FY2025 full-year figure at $3.4 billion, up 3.15% from the prior year.
- Operating Income was $837.0 million for Q2 2026 at Zoetis, up from $697.0 million in the prior quarter.
- Over five years, Operating Income peaked at $930.0 million in Q2 2025 and troughed at -$212.0 million in Q4 2024.
- A 5-year average of $556.4 million and a median of $718.0 million in 2023 frame the typical range for Operating Income.
- The widest YoY moves for Operating Income: up 23.13% in 2024, down 15.22% in 2024.
- Over 5 years, Operating Income stood at -$187.0 million in 2022, then advanced by 1.6% to -$184.0 million in 2023, then retreated by 15.22% to -$212.0 million in 2024, then advanced by 8.96% to -$193.0 million in 2025, then jumped by 533.68% to $837.0 million in 2026.
- The last three Operating Income figures came in at $837.0 million (Q2 2026), $697.0 million (Q1 2026), and -$193.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.55 Bn | 40.36 Bn | 779.09 Mn | 425.57 Mn |
| 2 | Zoetis | 30.68 Bn | 29.00 Bn | 1.05 Bn | 837.00 Mn |
| 3 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 248.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 48.16 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 1.93 Mn |
| 6 | Zhengye Biotechnology Holding | 75.05 Mn | 67.96 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -241,611.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 837.00 Mn |
| Mar 31, 2026 | 697.00 Mn |
| Dec 31, 2025 | -193.00 Mn |
| Sep 30, 2025 | 899.00 Mn |
| Jun 30, 2025 | 930.00 Mn |
| Mar 31, 2025 | 779.00 Mn |
| Dec 31, 2024 | -212.00 Mn |
| Sep 30, 2024 | 889.00 Mn |
| Jun 30, 2024 | 872.00 Mn |
| Mar 31, 2024 | 756.00 Mn |
| Dec 31, 2023 | -184.00 Mn |
| Sep 30, 2023 | 744.00 Mn |
| Jun 30, 2023 | 739.00 Mn |
| Mar 31, 2023 | 614.00 Mn |
| Dec 31, 2022 | -187.00 Mn |
| Sep 30, 2022 | 680.00 Mn |
| Jun 30, 2022 | 686.00 Mn |
| Mar 31, 2022 | 670.00 Mn |
| Dec 31, 2021 | -197.00 Mn |
| Sep 30, 2021 | 683.00 Mn |